milrinone has been researched along with pituitrin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Cullinane, S; Gold, JA; Landry, DW; Oliver, JA; Oz, MC | 1 |
| Chen, J; Cullinane, S; Gold, J; Landry, DW; Oliver, JA; Oz, MC; Seo, S | 1 |
| Ewald, G; Mindel, G; Saab, G; Vijayan, A | 1 |
| Sharma, M; Teerlink, JR | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Furnary, A; He, GW; Wei, W; Yang, CQ | 1 |
| Harjola, VP; Siirilä-Waris, K; Suojaranta-Ylinen, R | 1 |
| Bahk, JH; Choi, JY; Jeon, Y; Kim, CS; Lim, YJ; Ryu, JH; Yoon, SZ | 1 |
| Lange, M; Van Aken, H; Westphal, M | 1 |
| Albrecht, S; Heuser, F; Leuthold, C; Palmaers, T; Schmitz, B; Schuettler, J | 1 |
| Noori, S; Seri, I | 1 |
| Cataldi, L; Toth-Heyn, P | 1 |
| Christensen, M; Connolly, S; Goday, PS; Manzi, J; Mikhailov, TA; Panchal, AK; Wakeham, M | 1 |
| Lennmyr, F; Martijn, C; Semenas, E; Wiklund, L; Zoerner, F | 1 |
| Abdollahi, M; Baeeri, M; Baghaei, A; Chamanara, M; Gholami, M; Hassani, S; Jafari, A; Ostad, SN; Sharifzadeh, M; Solgi, R | 1 |
| Hilmi, I; Marquez, JM; Schisler, T; Subramaniam, K | 1 |
| Dempsey, E; Rabe, H | 1 |
| de Waal, K; Phad, N | 1 |
| Axelsson, B; Grafver, I; Jansson, K; Kiszakiewicz, L; Nilsson, KF; Oikonomakis, I; Seilitz, J | 1 |
| Chartan, CA; Coleman, RD; Mourani, PM | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
| Agbana, P; Bae, Y; Beckman, EJ; Gardner, B; Kenneally, AM; Mitchell, T | 1 |
| Chilson, K; Murray-Torres, RM; Sharma, A | 1 |
7 review(s) available for milrinone and pituitrin
| Article | Year |
|---|---|
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
Topics: Cardiotonic Agents; Cardiovascular System; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Humans; Hydrazones; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Milrinone; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2012 |
Vasoactive compounds in the neonatal period.
Topics: Adrenal Cortex Hormones; Cardiovascular System; Catecholamines; Humans; Hydrazones; Hypotension; Infant, Newborn; Milrinone; Pyridazines; Simendan; Vasodilator Agents; Vasopressins | 2012 |
The Use of Cardiotonic Drugs in Neonates.
Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Intensive Care Units, Neonatal; Milrinone; Neonatal Sepsis; Norepinephrine; Persistent Fetal Circulation Syndrome; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2019 |
What Inotrope and Why?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Echocardiography; Epinephrine; Heart; Humans; Hypotension; Infant, Newborn; Lactic Acid; Milrinone; Norepinephrine; Perfusion Index; Skin; Spectroscopy, Near-Infrared; Ultrasonography; Urination; Vasopressins | 2020 |
Intensive care management of right ventricular failure and pulmonary hypertension crises.
Topics: Biomarkers; Capnography; Central Venous Pressure; Critical Care; Echocardiography; Epinephrine; Epoprostenol; Extracorporeal Membrane Oxygenation; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Iloprost; Intensive Care Units; Milrinone; Nitric Oxide; Radiography, Thoracic; Respiration, Artificial; Spectroscopy, Near-Infrared; Vasodilator Agents; Vasopressins; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
2 trial(s) available for milrinone and pituitrin
| Article | Year |
|---|---|
Levosimendan in cardiac surgery.
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Disease; Epinephrine; Female; Follow-Up Studies; Hemodynamics; Humans; Hydrazones; Male; Milrinone; Norepinephrine; Postoperative Care; Preoperative Care; Pyridazines; Risk Factors; Simendan; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Ventricular Dysfunction, Left | 2005 |
Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Topics: Aged; Coronary Artery Bypass, Off-Pump; Double-Blind Method; Female; Humans; Hypotension; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2006 |
15 other study(ies) available for milrinone and pituitrin
| Article | Year |
|---|---|
Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Coronary Artery Bypass; Fatal Outcome; Female; Heart Valve Prosthesis Implantation; Humans; Hypotension; Male; Milrinone; Mitral Valve; Norepinephrine; Phosphodiesterase Inhibitors; Postoperative Period; Retrospective Studies; Vasoconstrictor Agents; Vasopressins | 2000 |
Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Failure; Humans; Hypotension; Injections, Intravenous; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Retrospective Studies; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents; Vasopressins | 2000 |
Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Amyloidosis; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Male; Middle Aged; Milrinone; Norepinephrine; Peritoneal Dialysis; Phenylephrine; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2002 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery.
Topics: Analysis of Variance; Coronary Artery Bypass; Drug Interactions; Female; Humans; Male; Mammary Arteries; Milrinone; Nitroglycerin; Nitroprusside; Probability; Radial Artery; Risk Factors; Sensitivity and Specificity; Tissue Culture Techniques; Vasoconstriction; Vasodilation; Vasodilator Agents; Vasopressins | 2005 |
Is vasopressin really superior to norepinephrine in reversing milrinone-induced vasodilation?
Topics: Coronary Artery Bypass; Humans; Hypotension; Milrinone; Norepinephrine; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2006 |
Milrinone combined with vasopressin improves cardiac index after cardiopulmonary resuscitation in a pig model of myocardial infarction.
Topics: Animals; Blood Pressure; Cardiopulmonary Resuscitation; Coronary Circulation; Disease Models, Animal; Drug Therapy, Combination; Male; Milrinone; Myocardial Infarction; Phosphodiesterase Inhibitors; Swine; Vasopressins | 2007 |
Vassopressors and inotropes.
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Milrinone; Norepinephrine; Phenylephrine; Vasoconstrictor Agents; Vasopressins | 2011 |
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine; Enteral Nutrition; Epinephrine; Female; Gastrointestinal Tract; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2016 |
Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest.
Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Cardiotonic Agents; Fluid Therapy; Heart Arrest; Heart Diseases; Male; Milrinone; Myocardium; Propanolamines; Survival Analysis; Swine; Troponin I; Vasoconstrictor Agents; Vasopressins | 2015 |
An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aluminum Compounds; Animals; Apoptosis; Biomarkers; Cardiotonic Agents; Caspase 3; Caspase 9; Electrocardiography; Heart Diseases; Lethal Dose 50; Milrinone; Mitochondria, Heart; Myocytes, Cardiac; Necrosis; Oxidative Stress; Oxygen Consumption; Phosphines; Rats; Vasoconstrictor Agents; Vasopressins | 2015 |
Pulmonary Hypertensive Crisis on Induction of Anesthesia.
Topics: Adrenergic alpha-Agonists; Anesthesia; Bronchodilator Agents; Calcium Chloride; Cardiopulmonary Resuscitation; Cardiotonic Agents; Epinephrine; Fatal Outcome; Female; Heart Arrest; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Middle Aged; Milrinone; Nitric Oxide; Norepinephrine; Sodium Bicarbonate; Vasoconstrictor Agents; Vasopressins | 2017 |
A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract.
Topics: Animals; Cardiac Output, Low; Disease Models, Animal; Female; Gastrointestinal Tract; Male; Milrinone; Norepinephrine; Random Allocation; Simendan; Splanchnic Circulation; Swine; Vasodilator Agents; Vasopressins | 2021 |
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
Topics: Anti-Bacterial Agents; Calcium Chloride; Drug Incompatibility; Epinephrine; Heparin; Humans; In Vitro Techniques; Infusions, Intravenous; Milrinone; Vasopressins | 2023 |
Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt.
Topics: Anesthesia, General; Anesthetics; Child; Dobutamine; Epinephrine; Humans; Hypertension, Pulmonary; Infant; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2024 |